WO2000061182A3 - Techniques et compositions pour le traitement et la prevention des maladies pulmonaires - Google Patents

Techniques et compositions pour le traitement et la prevention des maladies pulmonaires Download PDF

Info

Publication number
WO2000061182A3
WO2000061182A3 PCT/US2000/009494 US0009494W WO0061182A3 WO 2000061182 A3 WO2000061182 A3 WO 2000061182A3 US 0009494 W US0009494 W US 0009494W WO 0061182 A3 WO0061182 A3 WO 0061182A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
methods
compositions
prevention
lung disease
Prior art date
Application number
PCT/US2000/009494
Other languages
English (en)
Other versions
WO2000061182A2 (fr
Inventor
Roshantha A Chandraratna
Donald Massaro
Gloria Decarlo Massaro
Original Assignee
Allergan Sales Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales Inc filed Critical Allergan Sales Inc
Priority to AU42224/00A priority Critical patent/AU4222400A/en
Publication of WO2000061182A2 publication Critical patent/WO2000061182A2/fr
Publication of WO2000061182A3 publication Critical patent/WO2000061182A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des techniques et des compositions destinées au traitement des maladies pulmonaires telles que l'emphysème et/ou la dysplasie broncho-pulmonaire chez les mammifères. L'invention concerne également des techniques et des compositions favorisant la formation de septa alvéolaires et augmentant la surface d'échange gazeux d'un poumon de mammifère, destinées à la prévention et/ou au traitement de la destruction alvéolaire.
PCT/US2000/009494 1999-04-14 2000-04-11 Techniques et compositions pour le traitement et la prevention des maladies pulmonaires WO2000061182A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU42224/00A AU4222400A (en) 1999-04-14 2000-04-11 Methods and compositions for the treatment and prevention of lung disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12921499P 1999-04-14 1999-04-14
US60/129,214 1999-04-14

Publications (2)

Publication Number Publication Date
WO2000061182A2 WO2000061182A2 (fr) 2000-10-19
WO2000061182A3 true WO2000061182A3 (fr) 2001-03-29

Family

ID=22438926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/009494 WO2000061182A2 (fr) 1999-04-14 2000-04-11 Techniques et compositions pour le traitement et la prevention des maladies pulmonaires

Country Status (2)

Country Link
AU (1) AU4222400A (fr)
WO (1) WO2000061182A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286364A2 (fr) * 1987-04-06 1988-10-12 Riker Laboratories, Inc. Di-t-butylphénols substitués
WO1997019062A1 (fr) * 1995-11-22 1997-05-29 Allergan Arylamides ou heteroarylamides substitues ayant une activite biologique analogue a celle des retinoides
WO1997019052A1 (fr) * 1995-11-22 1997-05-29 Allergan Arylamides ou hetero-arylamides de tetrahydronaphtalene, de chromane, de thiochromane et d'acides carboxyliques 1,2,3,4-tetrahydroquinoliniques ayant une activite biologique de type retinoide
WO1998019999A1 (fr) * 1996-11-05 1998-05-14 Allergan Sales, Inc. Ligands tetrahydroquinolines, a substitution n-aryle, de recepteurs retinoides, possedant une activite du type agoniste, antagoniste ou agoniste inverse
US5919970A (en) * 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286364A2 (fr) * 1987-04-06 1988-10-12 Riker Laboratories, Inc. Di-t-butylphénols substitués
WO1997019062A1 (fr) * 1995-11-22 1997-05-29 Allergan Arylamides ou heteroarylamides substitues ayant une activite biologique analogue a celle des retinoides
WO1997019052A1 (fr) * 1995-11-22 1997-05-29 Allergan Arylamides ou hetero-arylamides de tetrahydronaphtalene, de chromane, de thiochromane et d'acides carboxyliques 1,2,3,4-tetrahydroquinoliniques ayant une activite biologique de type retinoide
WO1998019999A1 (fr) * 1996-11-05 1998-05-14 Allergan Sales, Inc. Ligands tetrahydroquinolines, a substitution n-aryle, de recepteurs retinoides, possedant une activite du type agoniste, antagoniste ou agoniste inverse
US5919970A (en) * 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHYTIL F: "The lungs and vitamin A.", AMERICAN JOURNAL OF PHYSIOLOGY, (1992 MAY) 262 (5 PT 1) L517-27, XP000978073 *
TENG M ET AL: "IDENTIFICATION OF A RETINOIC ACID RECEPTOR ALPHA SUBTYPE SPECIFIC AGONIST", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, vol. 39, no. 16, 2 August 1996 (1996-08-02), pages 3035 - 3038, XP000652115, ISSN: 0022-2623 *

Also Published As

Publication number Publication date
WO2000061182A2 (fr) 2000-10-19
AU4222400A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001284695A1 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2001277189A1 (en) Method and composition for the generation of chlorine dioxide using iodo-compounds, and methods of use
EP1128832A4 (fr) Composes, compositions et procedes pour traiter des infections virales et les maladies qui y sont liees
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
AU5898599A (en) Methods and compositions for genomic modification
AU2002234076A1 (en) Construction composition, structure, and method
AU3700400A (en) Frozen chlorine dioxide-containing composition and methods related thereto
AU2001235737A1 (en) Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
WO2000061233A3 (fr) Methodes et compositions de traitement et de prevention de maladies pulmonaires
AU7136700A (en) Potassium calcium citrate compositions and methods for production
AU2002367023A1 (en) Compositions and methods for treating heart failure
AU2002365057A1 (en) Compositions and methods for treating heart failure
AU2001275085A1 (en) Methods, compounds and compositions for treating gout
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
WO2000061232A3 (fr) Methodes et compositions destinees au traitement et a la prevention de maladies pulmonaires
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU4093399A (en) Compositions for regenerating tissue that has degenerated, and methods for using such compositions
WO2000061182A3 (fr) Techniques et compositions pour le traitement et la prevention des maladies pulmonaires
AU4413800A (en) Composition for use as nox trap, combining two compositions based on manganese and another element selected among the alkalines, alkaline-earths and rare earthsand use thereof for treating exhaust gases
AU2001234616A1 (en) Vaccine composition, process and methods
AU2003237088A1 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU2001291308A1 (en) Methods and compositions for treating nail fungus
AU2000257989A1 (en) Furnace crown and method for its construction
WO2001015777A8 (fr) Administration pulmonaire d'ascorbates mineraux

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP